Analyst I, Portfolio Analytics at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, BiotechnologyIndustries

Requirements

Bachelor's or master's degree in a relevant field such as Biology/Biotechnology, Finance, Business, Economics, or a related discipline (MBA a plus)
Proven experience (typically 1 to 3 years) in a forecasting role, preferably within the biopharma or pharmaceutical industry
Hands-on expertise in pharmaceutical forecasting and commercial analytics, modeling platforms, Advanced Excel & VBA, data manipulation software, and visualization tools
Experience with data analysis and modeling platforms; able to manipulate large datasets and build reusable templates/dashboards
Fluent with industry datasets for sales forecasts, Epi, & Competitive Intelligence
Previous experience in Hematology, Oncology, or Cell Therapy (Preferred but not required)
Strong analytical and problem-solving skills with an understanding of statistical forecasting techniques, time series analysis

Responsibilities

Partner with BD Analytics HOCT team to maintain comprehensive forecasting models and methodologies to project sales
Collaborate with cross-functional teams to gather and analyze relevant data, market trends, and historical performance
Apply advanced statistical analysis techniques and time series/predictive modeling to identify trends/drivers influencing forecasts
Conduct scenario analyses and simulation studies to evaluate the potential impact of various factors, such as market dynamics, pricing strategies, class or brand share evolution, and regulatory changes
Prepare and present forecast reports, dashboards, and presentations to communicate findings, insights, and recommendations to team members to align forecasts with business goals and strategies
Stay up-to-date with industry trends, emerging methodologies, and best practice forecasting and simulation
Translate complex data and analytics into clear, actionable insights that drive business decisions
Proactively and continuously assess the relevant marketplace and its dynamics, customers, competitors, and future development
Build new capabilities to automate data gathering and reporting that support key senior leadership forums
Collaborate with IT teams to optimize data infrastructure, enhance data collection, and leverage advanced analytics tools for forecasting and simulation purposes

Skills

Excel

Forecasting Models

Statistical Models

Simulation Methodologies

Sales Forecasting

Epidemiology

Competitive Intelligence

Pharmaceutical Valuation

Commercial Analytics

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free